Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Ticevis 10mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, round, convex tablets. |
Each tablet contains 10 mg loratadine.
Excipient with known effect: lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Loratadine |
Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage. |
| List of Excipients |
|---|
|
Lactose monohydrate |
Tablets are packed into PVC-Al blisters in a carton box with a patient information leaflet.
Boxes of 10, 20 and 30 are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
18730
Date of first authorization: 01.03.2000
Date of renewal: 16.01.2013
| Drug | Countries | |
|---|---|---|
| TICEVIS | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
